Additionally, exploring ITE’s role in other MMP-9–driven inflammatory conditions, such as cardiovascular disease and autoimmune disorders, may further validate its potential as a novel anti-inflammatory therapeutic agent. The gene discussed is MMP9; the disease is cardiovascular disorder.